CU docs work to boost minorities in (and leading) cancer trials

Focus on training minority investigators By Todd Neff Clinical trials of cancer therapies are most…

Read the rest of this entry

CU Cancer Center, MD Anderson awarded joint $4.25M grant to develop early-phase clinical trials

The University of Colorado Cancer Center and The University of Texas MD Anderson Cancer Center…

Read the rest of this entry

Study Highlights New Drug, Molecular Insight into Triple Negative Breast Cancers

AACR 2014 study showcases a new drug active against triple-negative breast cancer, and through analysis of the drug’s mechanism of action, offers increased understanding of the biology of this very aggressive form of breast cancer.

Read the rest of this entry

Phase II trial of efatutazone shows challenge of matching treatment to population

AACR Research Results: While efatutazone did not improve the efficacy of erlotinib in this trial, researchers hope lessons from the trial will allow them to make better future use of the drug or other drugs in its class.

Read the rest of this entry

Gold nanorods attach to, kill bladder cancer cells

Bladder cancer cells overexpress the protein EGFR; gold nanorods can be engineered to attach to EGFR proteins; and then the application of low-intensity laser to the tissue can preferentially heat these gold nanorods, killing the EGFR-rich cancer cells to which they are attached.

Read the rest of this entry

Milk Thistle Extract, Silibinin, Reduces Self-Renewal of Colorectal Cancer Stem Cells

A University of Colorado Cancer Center study presented today at the American Association for Cancer Research (AACR) Annual Meeting 2014 shows that the chemical silibinin, purified from milk thistle extract, affects cell signaling associated with inflammation and thus also the formation and survival of colorectal cancer stem cells.

Read the rest of this entry

Non-Invasive Imaging Instead of Repeated Biopsy in Active Monitoring of Prostate Cancer

A University of Colorado Cancer Center study being presented today at the American Association for Cancer Research (AACR) Annual Meeting 2014 describes a novel method to “manipulate the lipid metabolism in the cancer cell to trick them to use more radiolabeled glucose, the basis of PET scanning.”

Read the rest of this entry

Zombie Cancer Cells Eat Themselves to Live

AACR 2014 study shows that the cellular process of autophagy in which cells “eat” parts of themselves in times of stress may allow cancer cells to recover and divide rather than die when faced with chemotherapies.

Read the rest of this entry

Major Genetic Study Links Liver Disease Gene to Bladder Cancer

A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented tomorrow at the American Association for Cancer Research Annual Conference 2014) details the discovery of a new genetic driver of bladder cancer: silencing of the gene AGL.

Read the rest of this entry

Mike Shaw Subaru raises $11k for CU Cancer Center

This week Mike Shaw Subaru donated more than $11,000 to the University of Colorado Cancer…

Read the rest of this entry